Cholestyramine orally administered to patients with erythropoietic protoporphyria results in urinary excretion of protoporphyrin: to be explained by the Herbst-Volkheimer effect?
Beukeveld
G J
GJ
Central Laboratory for Clinical Chemistry, University Hospital Groningen, The Netherlands.
Wolthers
B G
BG
D000284:Administration, Oral; D000293:Adolescent; D000368:Aged; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D017121:Porphyria, Hepatoerythropoietic / Q000652:urine*; D011524:Protoporphyrins / Q000652:urine*
D011524:Protoporphyrins; D002792:Cholestyramine Resin